RHOJ overexpression in EPCAM+ tumour cells strongly decreased the proportion of apoptotic tumour cells 24 h after cisplatin/5FU administration and leads to increased cell survival 48 h after chemotherapy (Fig. 2d,e and Extended Data Fig. 3a,b). Here, RHOJ is linked to neoplasm.